Abstract
Cefatrizine, a new orally administered cephalosporin, was tested against 400 clinical isolates. Cefatrizine had excellent activity against gram-positive cocci, inhibiting all except enterococci at minimal inhibitory concentrations below 1 μg/ml. Cefatrizine inhibited the majority of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella at concentrations below 12.5 μg/ml. Although cefatrizine was not hydrolyzed by many β-lactamases, it did not inhibit a number of strains of Enterobacter, Serratia, or indole-positive Proteus. Cefatrizine was more active than cephalothin or cephalexin against E. coli, Klebsiella, Enterobacter, Citrobacter, Salmonella, and Shigella. Its overall activity was less than that of cefoxitin against strains resistant to cephalothin, but its activity against cephalothin-susceptible strains was equivalent to that of cefamandole.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blackwell C. C., Freimer E. H., Tuke G. C. In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins. Antimicrob Agents Chemother. 1976 Aug;10(2):288–292. doi: 10.1128/aac.10.2.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leitner F., Buck R. E., Misiek M., Pursiano T. A., Price K. E. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro. Antimicrob Agents Chemother. 1975 Mar;7(3):298–305. doi: 10.1128/aac.7.3.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother. 1974 Aug;6(2):177–182. doi: 10.1128/aac.6.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother. 1974 Aug;6(2):170–176. doi: 10.1128/aac.6.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Callaghan C. H., Sykes R. B., Griffiths A., Thornton J. E. Cefuroxime, a new cephalosporin antibiotic: activity in vitro. Antimicrob Agents Chemother. 1976 Mar;9(3):511–519. doi: 10.1128/aac.9.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Overturf G. D., Ressler R. L., Marengo P. B., Wilkins J. In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic. Antimicrob Agents Chemother. 1975 Sep;8(3):305–310. doi: 10.1128/aac.8.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stilwell G. A., Adams H. G., Turck M. In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640). Antimicrob Agents Chemother. 1975 Dec;8(6):751–753. doi: 10.1128/aac.8.6.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanakunakorn C., Bannister T., Glotzbecker C. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin. Antimicrob Agents Chemother. 1975 Mar;7(3):381–385. doi: 10.1128/aac.7.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]